Shots:

• The collaboration will merge Microsoft’s computational services- cloud and AI with UCB’s drug discovery and development capabilities
• The companies intend to discover and develop medicines for people living with severe diseases in immunology and neurology. The collaboration follows UCB and Microsoft’s collaboration around COVID-19
• Microsoft will provide AI technology and applied scientists to work alongside UCB's scientist and data specialist that will allow UCB to discover new correlations and patterns critical to find new and highly individualized medicines

 ­ Ref: PRNewswire | Image: PRNewswire